levensten law firm logo

Profits over Patient Safety: Pradaxa TV Commercials Continue To Flood The Networks

Steps taken by the international pharmaceutical corporation Boehringer Ingelheim pursuant to the development of Pradaxa, an FDA – approved prescription medicine designed to help reduce the risk of stroke in persons with nonvalvular atrial fibrillation, demonstrate the company’s purely profit – driven motivation with respect to the drugs distribution. Moreover, Pradaxa is expected to be […]

Pradaxa Side Effects Outweigh Any Supposed Benefit In Terms of Patient Safety

While Pradaxa, a recently developed oral anticoagulant intended to combat the risk of stroke in patients with atrial fibrillation (AF), was created with an eye to sidestepping many of the limitations associated with Warfarin, Pradaxa’s main competitor, new and potentially more dangerous hazards have arisen with respect to its prescription. Boehringer Ingelheim, the international pharmaceutical […]


Your Warriors for Justice
Fight fearlessly. Win strategically.